Autres langues Caplin Point Laboratories Limited NSE India S.E.

Actions

CAPLIPOINT

INE475E01026

Produits pharmaceutiques

Temps Différé NSE India S.E. 09:11:39 23/06/2026 Varia. 5j. Varia. 1 janv.
2 478,20 INR -2,33 % Graphique intraday de Caplin Point Laboratories Limited +4,41 % +35,06 %

Autres langues

14/05 Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
14/05 Caplin Steriles Limited Gets Usfda Approval for Foscarnet Sodium Injection
14/05 Caplin Point Laboratories' Consolidated Profit Rises in Fiscal Q4; Shares Jump 10%
14/05 Caplin Point Laboratories March-quarter consol net profit 1.7 bln rupees
05/05 Caplin Point Laboratories Unit Gets US FDA's Final Nod for Calcium Gluconate Injection
13/03 Caplin Point Laboratories Unit Gets US FDA's Nod for Potassium Phosphates Injection
13/03 Caplin Point Laboratories unit receives final USFDA approval for ANDA potassium phosphates injection
03/03 Caplin Point Laboratories Limited Announces Cessation of C K Gariyali as Independent Director, with Effect from the Close of Business Hours on March 03, 2026
24/02 Indian Markets Slide on Tuesday as Global Trade Concerns Weigh
24/02 Caplin Point Laboratories Arm Gets US FDA's Final Approval for Sodium Phosphates Injection
24/02 Caplin Point Laboratories says unit receives USFDA approval for sodium phosphates injection
05/02 Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
05/02 Caplin Point Laboratories Dec-quarter consol net profit 1.64 billion rupees
03/02 Caplin Point Laboratories Limited Announces Changes to Its Board
27/01 Caplin Point Laboratories unit receives USFDA approval for methylprednisolone acetate
09/12 Caplin Point Laboratories Gets US FDA Nod for Linezolid Injection
09/12 Caplin Point Laboratories unit gets USFDA final approval for Linezolid Injection, Infusion bags
08/12 Caplin Point Laboratories unit receives final US FDA approval for its ANDA Acetaminophen Injection
05/11 Caplin Point Laboratories appoints Ashok Partheeban as vice-chairman
05/11 Caplin Point Laboratories Limited Announces Executive Changes , Effective November 5, 2025
05/11 Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
05/11 Caplin Point Laboratories Sept-quarter consol net profit 1.54 billion rupees
23/10/25 Caplin Point Laboratories says Caplin Steriles receives USFDA approval for Nicardipine Injection
03/09/25 Caplin Steriles Limited Receives Final Approval from the United States Food and Drug Administration for its Abbreviated New Drug Application Milrinone Lactate in 5% Dextrose Injection
07/08/25 Caplin Point Laboratories' Consolidated Profit Rises in Fiscal Q1; Shares Up 3%
Aucun résultat pour cette recherche
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇